Jeffrey S Farrow
CIK 1405253 · See Remarks · last filed 2026-07-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.91M
Companies
5
Total Filings
63
Lifetime Open-Market Net
-$6.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACHV | Director | — | $7.25 | — | $0 | 2 | 2026-07-29 |
| TARS | See Remarks | 56,801 | $68.88 | $3.91M | -$2.33M | 11 | 2026-06-17 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Chief Financial Officer | 0 | $68.49 | $0 | -$4.30M | 29 | 2022-10-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | CFO | 0 | — | — | $0 | 7 | 2015-05-08 |
| RENOVIS INC (RNVS) Delisted | V.P., Finance and CAO | 62,286 | — | — | $0 | 3 | 2008-02-12 |
Recent Filings · Page 2 of 7
63 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-18 | TARS | Mixed | +14,273 | -$550.0K | EDGAR |
| 2025-06-17 | TARS | Notice (144) | −13,608 | -$550.1K | EDGAR |
| 2025-03-20 | TARS | Notice (144) | −1,186 | -$59.4K | EDGAR |
| 2025-03-20 | TARS | Sell (S) | −3,724 | -$178.3K | EDGAR |
| 2025-03-19 | TARS | Notice (144) | −1,254 | -$59.4K | EDGAR |
| 2025-03-18 | TARS | Notice (144) | −1,284 | -$59.4K | EDGAR |
| 2025-03-18 | TARS | Exer (M) | +8,019 | $0 | EDGAR |
| 2025-03-07 | TARS | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | TARS | Mixed | +17,436 | -$286.9K | EDGAR |
| 2024-06-18 | TARS | Notice (144) | −10,445 | -$287.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.